Holdings of NYLIM VP Wellington Small Cap Portfolio
NYLIM VP FUNDS TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 429.2M $ including 408M $ in equities, 95.0 %
- Positions
- 266 in 8 countries
- Top ten
- 13.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Kratos Defense & Security Solutions Inc | 10,171 | 507.1K $ | 0.12 % |
| 202 | HMH Holding Inc | 25,915 | 485.6K $ | 0.11 % |
| 203 | TG THERAPEUTICS INC | 8,680 | 476.9K $ | 0.11 % |
| 204 | Corvus Pharmaceuticals Inc | 28,457 | 425.1K $ | 0.10 % |
| 205 | TWIST BIOSCIENCE CORP | 3,948 | 406.2K $ | 0.09 % |
| 206 | Ligand Pharmaceuticals Inc | 1,241 | 392.3K $ | 0.09 % |
| 207 | Mineralys Therapeutics Inc | 14,493 | 391K $ | 0.09 % |
| 208 | Applied Aerospace & Defense Inc | 16,945 | 386K $ | 0.09 % |
| 209 | Rhythm Pharmaceuticals Inc | 3,395 | 376.9K $ | 0.09 % |
| 210 | ServiceTitan Inc | 5,325 | 376.5K $ | 0.09 % |
| 211 | Terawulf Inc | 14,042 | 346.8K $ | 0.08 % |
| 212 | Hims & Hers Health Inc | 9,770 | 338.7K $ | 0.08 % |
| 213 | Liquidia Corp | 4,175 | 332.9K $ | 0.08 % |
| 214 | CRISPR Therapeutics AG | 6,003 | 327.4K $ | 0.08 % |
| 215 | Indivior Pharmaceuticals Inc | 7,839 | 321.6K $ | 0.07 % |
| 216 | MIRUM PHARMACEUTICALS INC | 2,721 | 318.5K $ | 0.07 % |
| 217 | Veracyte Inc | 5,138 | 301.8K $ | 0.07 % |
| 218 | TRAVERE THERAPEUTICS INC | 5,183 | 294.4K $ | 0.07 % |
| 219 | ORUKA THERAPEUTICS INC | 2,968 | 282.5K $ | 0.07 % |
| 220 | Taysha Gene Therapies Inc | 40,120 | 273.2K $ | 0.06 % |
| 221 | Alight Inc | 425,555 | 238.3K $ | 0.06 % |
| 222 | Denali Therapeutics Inc | 9,069 | 233.3K $ | 0.05 % |
| 223 | Erasca Inc | 12,325 | 225.8K $ | 0.05 % |
| 224 | Tango Therapeutics Inc | 7,158 | 223.8K $ | 0.05 % |
| 225 | Beam Therapeutics Inc | 6,258 | 214.8K $ | 0.05 % |
| 226 | ACADIA Pharmaceuticals Inc | 8,028 | 203.1K $ | 0.05 % |
| 227 | IMMUNOVANT INC | 5,253 | 202.4K $ | 0.05 % |
| 228 | Ideaya Biosciences Inc | 5,414 | 201.8K $ | 0.05 % |
| 229 | Janus Living Inc | 6,860 | 197.2K $ | 0.05 % |
| 230 | DYNE THERAPEUTICS INC | 8,419 | 187K $ | 0.04 % |
| 231 | Arcutis Biotherapeutics Inc | 7,081 | 185.7K $ | 0.04 % |
| 232 | Edgewise Therapeutics Inc | 4,422 | 179.7K $ | 0.04 % |
| 233 | Relay Therapeutics Inc | 9,105 | 170.4K $ | 0.04 % |
| 234 | VERA THERAPEUTICS INC | 3,962 | 170K $ | 0.04 % |
| 235 | SELLAS Life Sciences Group Inc | 11,381 | 168K $ | 0.04 % |
| 236 | IMMUNITYBIO INC | 19,077 | 167K $ | 0.04 % |
| 237 | Amneal Pharmaceuticals Inc | 9,612 | 166.4K $ | 0.04 % |
| 238 | Fervo Energy Co | 5,645 | 165K $ | 0.04 % |
| 239 | ARCUS BIOSCIENCES INC | 5,338 | 164.6K $ | 0.04 % |
| 240 | Supernus Pharmaceuticals Inc | 3,538 | 164.6K $ | 0.04 % |
| 241 | GRAIL Inc | 2,369 | 161.7K $ | 0.04 % |
| 242 | Nurix Therapeutics Inc | 6,605 | 160.2K $ | 0.04 % |
| 243 | TARSUS PHARMACEUTICALS INC | 2,542 | 160K $ | 0.04 % |
| 244 | CYBERARK SOFTWARE LTD | 3,524 | 158.6K $ | 0.04 % |
| 245 | Prestige Consumer Healthcare Inc | 3,101 | 146.6K $ | 0.03 % |
| 246 | BioCryst Pharmaceuticals Inc | 14,476 | 144.8K $ | 0.03 % |
| 247 | Vericel Corp | 3,225 | 143.5K $ | 0.03 % |
| 248 | Immunome Inc | 6,645 | 140.8K $ | 0.03 % |
| 249 | Agios Pharmaceuticals Inc | 3,598 | 133.5K $ | 0.03 % |
| 250 | Enliven Therapeutics Inc | 2,543 | 129.1K $ | 0.03 % |
| 251 | Aurinia Pharmaceuticals Inc | 7,523 | 127.7K $ | 0.03 % |
| 252 | ADMA Biologics Inc | 15,052 | 126K $ | 0.03 % |
| 253 | Intellia Therapeutics Inc | 7,445 | 126K $ | 0.03 % |
| 254 | ALUMIS INC | 4,454 | 125.3K $ | 0.03 % |
| 255 | Syndax Pharmaceuticals Inc | 5,577 | 121.9K $ | 0.03 % |
| 256 | OCULAR THERAPEUTIX INC | 12,323 | 121K $ | 0.03 % |
| 257 | Recursion Pharmaceuticals Inc | 31,126 | 114.2K $ | 0.03 % |
| 258 | Innoviva Inc | 4,795 | 108.9K $ | 0.03 % |
| 259 | Stoke Therapeutics Inc | 3,130 | 102.4K $ | 0.02 % |
| 260 | Harmony Biosciences Holdings Inc | 2,796 | 101.8K $ | 0.02 % |
| 261 | ANI Pharmaceuticals Inc | 1,206 | 99.8K $ | 0.02 % |
| 262 | Novavax Inc | 9,847 | 92.8K $ | 0.02 % |
| 263 | Iovance Biotherapeutics Inc | 22,016 | 91.6K $ | 0.02 % |
| 264 | Kodiak Sciences Inc | 2,348 | 91.5K $ | 0.02 % |
| 265 | Ardelyx Inc | 15,573 | 79.4K $ | 0.02 % |
| 266 | X-Energy Inc | 2,646 | 48.6K $ | 0.01 % |
Sector breakdown
- Technology 1.8 %
- Materials 1.1 %
- Health care 0.3 %
- Unattributed 96.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.9 %
- CAD 1.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.1 %
- Canada 1.9 %
- Israel 1.0 %
- Cayman Islands 0.9 %
- Bermuda 0.9 %
- United Kingdom 0.8 %
- Ireland 0.4 %
- Switzerland 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 252 | 384M $ | 94.14 % |
| 2 | Canada | 4 | 7.6M $ | 1.85 % |
| 3 | Israel | 3 | 4.2M $ | 1.04 % |
| 4 | Cayman Islands | 2 | 3.6M $ | 0.89 % |
| 5 | Bermuda | 2 | 3.5M $ | 0.86 % |
| 6 | United Kingdom | 1 | 3.2M $ | 0.78 % |
| 7 | Ireland | 1 | 1.5M $ | 0.36 % |
| 8 | Switzerland | 1 | 327.4K $ | 0.08 % |
Cite this page
Titelia. "Holdings of NYLIM VP Wellington Small Cap Portfolio". https://titelia.com/en/funds/S000053035